Recommended respiratory tests are not routinely performed for mucopolysaccharidosis patients

Area of Science:

• Medical Research
• Rare Diseases
• Clinical Trials

Background:

• Mucopolysaccharidoses (MPS) are rare genetic disorders requiring effective treatment monitoring.
• Clinical trials for MPS treatments rely on specific outcome measures, including respiratory tests.
• Patient compliance is essential for accurate and reliable clinical trial data.

Purpose of the Study:

• To evaluate the feasibility of routine respiratory testing in clinical practice for patients with MPS.
• To identify challenges associated with patient compliance during respiratory assessments in MPS.
• To assess the suitability of current respiratory tests as major outcomes in MPS clinical trials.

Main Methods:

• Review of clinical trial protocols for MPS treatments.
• Analysis of patient compliance data related to respiratory function tests.
• Assessment of neurocognitive and motor skill impacts on test performance in MPS patients.

Main Results:

• Recommended respiratory tests are not routinely feasible in clinical practice for most MPS patients.
• Neurocognitive impairment and motor skill difficulties significantly affect patient compliance.
• Current standard respiratory tests pose challenges for consistent data collection in routine care.

Conclusions:

• The utility of standard respiratory tests as primary outcome measures in MPS clinical trials is limited by patient compliance issues.
• Alternative or adapted assessment methods may be needed for effective monitoring of MPS patients in clinical practice.
• Further research is required to develop patient-centered outcome measures for MPS treatment evaluation.